AAPL327.50+12.64 (+4.01%) ▲|ABBV244.11+1.06 (+0.44%) ▲|ABT89.27+0.94 (+1.06%) ▲|ACN137.02+2.46 (+1.83%) ▲|ADBE224.56+3.78 (+1.71%) ▲|AMAT579.43-16.27 (-2.73%) ▼|AMD529.14-18.99 (-3.46%) ▼|AMGN358.32+3.07 (+0.86%) ▲|AMT168.63-0.20 (-0.12%) ▼|AMZN254.96+7.47 (+3.02%) ▲|AVGO394.28+5.17 (+1.33%) ▲|AXP358.44+3.38 (+0.95%) ▲|BA218.12+1.01 (+0.47%) ▲|BAC61.59+0.97 (+1.60%) ▲|BKNG182.80+7.95 (+4.55%) ▲|BLK1,093.40+67.96 (+6.63%) ▲|BMY58.72+1.77 (+3.11%) ▲|BNY162.35+7.85 (+5.08%) ▲|BRK-B488.35-2.74 (-0.56%) ▼|C134.89+1.62 (+1.22%) ▲|CAT914.30-19.04 (-2.04%) ▼|CL91.47+0.44 (+0.48%) ▲|CMCSA23.49+0.30 (+1.29%) ▲|COF208.89+3.60 (+1.75%) ▲|COP111.46-0.41 (-0.37%) ▼|COST916.54-5.21 (-0.57%) ▼|CRM167.00-0.56 (-0.33%) ▼|CSCO111.77-5.32 (-4.54%) ▼|CVS105.91-0.27 (-0.25%) ▼|CVX181.60-0.16 (-0.09%) ▼|DE589.48+5.08 (+0.87%) ▲|DHR200.79+1.74 (+0.87%) ▲|DIS97.15+1.28 (+1.34%) ▲|DUK124.34-2.03 (-1.61%) ▼|EMR136.25+0.16 (+0.12%) ▲|FDX313.42-0.24 (-0.08%) ▼|GD365.63-3.87 (-1.05%) ▼|GE360.35+6.62 (+1.87%) ▲|GEV1,055.28-10.73 (-1.01%) ▼|GILD131.70+1.66 (+1.28%) ▲|GM77.64+0.77 (+1.00%) ▲|GOOG370.21+12.88 (+3.60%) ▲|GOOGL370.92+11.41 (+3.17%) ▲|GS1,152.07+12.07 (+1.06%) ▲|HD341.44+3.70 (+1.10%) ▲|HON222.84+0.16 (+0.07%) ▲|IBM211.20-5.87 (-2.70%) ▼|INTC102.99-4.77 (-4.43%) ▼|INTU279.70-2.73 (-0.97%) ▼|ISRG388.97+9.47 (+2.50%) ▲|JNJ247.02-6.83 (-2.69%) ▼|JPM346.91+4.02 (+1.17%) ▲|KO82.45-0.63 (-0.76%) ▼|LIN514.15-8.39 (-1.61%) ▼|LLY1,156.63+4.09 (+0.35%) ▲|LMT514.46-0.53 (-0.10%) ▼|LOW209.66+1.98 (+0.95%) ▲|LRCX335.43-10.67 (-3.08%) ▼|MA535.21-2.81 (-0.52%) ▼|MCD264.95-3.99 (-1.48%) ▼|MDLZ58.72-0.08 (-0.14%) ▼|MDT80.47+1.17 (+1.48%) ▲|META681.31+20.27 (+3.07%) ▲|MMM160.53+3.95 (+2.52%) ▲|MO70.52+0.36 (+0.51%) ▲|MRK123.61+2.83 (+2.34%) ▲|MS228.55+0.88 (+0.39%) ▲|MSFT395.63+10.70 (+2.78%) ▲|MU904.28-78.84 (-8.02%) ▼|NEE89.10-0.44 (-0.49%) ▼|NFLX73.68+0.15 (+0.20%) ▲|NKE42.77-0.09 (-0.21%) ▼|NOW104.73-0.12 (-0.11%) ▼|NVDA212.50+0.70 (+0.33%) ▲|ORCL132.49+4.55 (+3.56%) ▲|PEP135.40-0.05 (-0.04%) ▼|PFE24.82+0.57 (+2.35%) ▲|PG148.05+1.97 (+1.35%) ▲|PLTR133.76+0.04 (+0.03%) ▲|PM180.88+4.93 (+2.80%) ▲|QCOM177.98-0.12 (-0.07%) ▼|RTX195.89+2.50 (+1.29%) ▲|SBUX105.11-1.06 (-1.00%) ▼|SCHW102.79+1.69 (+1.67%) ▲|SO94.60-1.36 (-1.42%) ▼|SPG222.01+0.73 (+0.33%) ▲|T21.43+0.15 (+0.70%) ▲|TMO535.29+1.22 (+0.23%) ▲|TMUS187.62+0.49 (+0.26%) ▲|TSLA394.46-1.72 (-0.43%) ▼|TXN301.19-4.36 (-1.43%) ▼|UBER72.67+0.59 (+0.82%) ▲|UNH418.52-6.67 (-1.57%) ▼|UNP288.36+0.06 (+0.02%) ▲|UPS112.94-0.73 (-0.64%) ▼|USB63.01+0.87 (+1.40%) ▲|V355.14-0.88 (-0.25%) ▼|VZ42.83+0.36 (+0.85%) ▲|WFC87.51+2.22 (+2.60%) ▲|WMT112.53-1.17 (-1.03%) ▼|XOM144.51-0.58 (-0.40%) ▼|AAPL327.50+12.64 (+4.01%) ▲|ABBV244.11+1.06 (+0.44%) ▲|ABT89.27+0.94 (+1.06%) ▲|ACN137.02+2.46 (+1.83%) ▲|ADBE224.56+3.78 (+1.71%) ▲|AMAT579.43-16.27 (-2.73%) ▼|AMD529.14-18.99 (-3.46%) ▼|AMGN358.32+3.07 (+0.86%) ▲|AMT168.63-0.20 (-0.12%) ▼|AMZN254.96+7.47 (+3.02%) ▲|AVGO394.28+5.17 (+1.33%) ▲|AXP358.44+3.38 (+0.95%) ▲|BA218.12+1.01 (+0.47%) ▲|BAC61.59+0.97 (+1.60%) ▲|BKNG182.80+7.95 (+4.55%) ▲|BLK1,093.40+67.96 (+6.63%) ▲|BMY58.72+1.77 (+3.11%) ▲|BNY162.35+7.85 (+5.08%) ▲|BRK-B488.35-2.74 (-0.56%) ▼|C134.89+1.62 (+1.22%) ▲|CAT914.30-19.04 (-2.04%) ▼|CL91.47+0.44 (+0.48%) ▲|CMCSA23.49+0.30 (+1.29%) ▲|COF208.89+3.60 (+1.75%) ▲|COP111.46-0.41 (-0.37%) ▼|COST916.54-5.21 (-0.57%) ▼|CRM167.00-0.56 (-0.33%) ▼|CSCO111.77-5.32 (-4.54%) ▼|CVS105.91-0.27 (-0.25%) ▼|CVX181.60-0.16 (-0.09%) ▼|DE589.48+5.08 (+0.87%) ▲|DHR200.79+1.74 (+0.87%) ▲|DIS97.15+1.28 (+1.34%) ▲|DUK124.34-2.03 (-1.61%) ▼|EMR136.25+0.16 (+0.12%) ▲|FDX313.42-0.24 (-0.08%) ▼|GD365.63-3.87 (-1.05%) ▼|GE360.35+6.62 (+1.87%) ▲|GEV1,055.28-10.73 (-1.01%) ▼|GILD131.70+1.66 (+1.28%) ▲|GM77.64+0.77 (+1.00%) ▲|GOOG370.21+12.88 (+3.60%) ▲|GOOGL370.92+11.41 (+3.17%) ▲|GS1,152.07+12.07 (+1.06%) ▲|HD341.44+3.70 (+1.10%) ▲|HON222.84+0.16 (+0.07%) ▲|IBM211.20-5.87 (-2.70%) ▼|INTC102.99-4.77 (-4.43%) ▼|INTU279.70-2.73 (-0.97%) ▼|ISRG388.97+9.47 (+2.50%) ▲|JNJ247.02-6.83 (-2.69%) ▼|JPM346.91+4.02 (+1.17%) ▲|KO82.45-0.63 (-0.76%) ▼|LIN514.15-8.39 (-1.61%) ▼|LLY1,156.63+4.09 (+0.35%) ▲|LMT514.46-0.53 (-0.10%) ▼|LOW209.66+1.98 (+0.95%) ▲|LRCX335.43-10.67 (-3.08%) ▼|MA535.21-2.81 (-0.52%) ▼|MCD264.95-3.99 (-1.48%) ▼|MDLZ58.72-0.08 (-0.14%) ▼|MDT80.47+1.17 (+1.48%) ▲|META681.31+20.27 (+3.07%) ▲|MMM160.53+3.95 (+2.52%) ▲|MO70.52+0.36 (+0.51%) ▲|MRK123.61+2.83 (+2.34%) ▲|MS228.55+0.88 (+0.39%) ▲|MSFT395.63+10.70 (+2.78%) ▲|MU904.28-78.84 (-8.02%) ▼|NEE89.10-0.44 (-0.49%) ▼|NFLX73.68+0.15 (+0.20%) ▲|NKE42.77-0.09 (-0.21%) ▼|NOW104.73-0.12 (-0.11%) ▼|NVDA212.50+0.70 (+0.33%) ▲|ORCL132.49+4.55 (+3.56%) ▲|PEP135.40-0.05 (-0.04%) ▼|PFE24.82+0.57 (+2.35%) ▲|PG148.05+1.97 (+1.35%) ▲|PLTR133.76+0.04 (+0.03%) ▲|PM180.88+4.93 (+2.80%) ▲|QCOM177.98-0.12 (-0.07%) ▼|RTX195.89+2.50 (+1.29%) ▲|SBUX105.11-1.06 (-1.00%) ▼|SCHW102.79+1.69 (+1.67%) ▲|SO94.60-1.36 (-1.42%) ▼|SPG222.01+0.73 (+0.33%) ▲|T21.43+0.15 (+0.70%) ▲|TMO535.29+1.22 (+0.23%) ▲|TMUS187.62+0.49 (+0.26%) ▲|TSLA394.46-1.72 (-0.43%) ▼|TXN301.19-4.36 (-1.43%) ▼|UBER72.67+0.59 (+0.82%) ▲|UNH418.52-6.67 (-1.57%) ▼|UNP288.36+0.06 (+0.02%) ▲|UPS112.94-0.73 (-0.64%) ▼|USB63.01+0.87 (+1.40%) ▲|V355.14-0.88 (-0.25%) ▼|VZ42.83+0.36 (+0.85%) ▲|WFC87.51+2.22 (+2.60%) ▲|WMT112.53-1.17 (-1.03%) ▼|XOM144.51-0.58 (-0.40%) ▼|
25 C
New York
Thursday, July 16, 2026

Tag: development

New data demonstrates robust efficacy of Vyepti® (eptinezumab) in otherwise difficult-to-treat patients with severe migraine

The full results of the phase IV RESOLUTION trial were presented at the European Academy of Neurology 2025 Annual Congress, where Vyepti® (eptinezumab) demonstrated...

New data from phase III trial confirms efficacy of Vyepti® (eptinezumab) in Asian population with chronic migraine

The full results of the phase III registrational SUNRISE trial were presented at the European Academy of Neurology 2025 Annual Congress, where eptinezumab demonstrated statistically...

New data from phase III trial confirms efficacy of Vyepti® (eptinezumab) in Asian population with chronic migraine

The full results of the phase III registrational SUNRISE trial were presented at the European Academy of Neurology 2025 Annual Congress, where eptinezumab demonstrated statistically...

IIM Udaipur Concludes Executive Education Training Program for PM SHRI School Principals in Collaboration with RSSP Jaipur

UDAIPUR, India, June 21, 2025 /PRNewswire/ -- Indian Institute of Management Udaipur (IIM Udaipur), in collaboration with the Rajasthan School Shiksha Parishad (RSSP), Jaipur,...

Dialogue on China-ASEAN Cultural Heritage Successfully Concludes in Tianshui

TIANSHUI, China, June 21, 2025 /PRNewswire/ -- To encourage exchange and cooperation in cultural heritage preservation, promote mutual learning among civilizations, and advance the...

Gan & Lee Pharmaceuticals Presented Multiple Results in Novel Diabetes Therapies at the American Diabetes Association’s 85th Scientific Sessions

In a Phase 2a clinical trial, the GLP-1 RA bofanglutide injection demonstrated a favorable safety and tolerability profile after 23 weeks of once weekly...

Gan & Lee Pharmaceuticals Presented Multiple Results in Novel Diabetes Therapies at the American Diabetes Association’s 85th Scientific Sessions

In a Phase 2a clinical trial, the GLP-1 RA bofanglutide injection demonstrated a favorable safety and tolerability profile after 23 weeks of once weekly...

Gan & Lee Pharmaceuticals Presented Multiple Results in Novel Diabetes Therapies at the American Diabetes Association’s 85th Scientific Sessions

In a Phase 2a clinical trial, the GLP-1 RA bofanglutide injection demonstrated a favorable safety and tolerability profile after 23 weeks of once weekly...

SIFF 2025: The Premier Launchpad for Chinese Movies and Their Global Promotion

SHANGHAI, June 21, 2025 /PRNewswire/ -- The 27th Shanghai International Film Festival (SIFF) is currently in full swing, vividly demonstrating the booming momentum of...

Potential Tax Changes Under Trump—Evaluate the Impact on Holiday Financial Planning

In 2012, I encountered Dane Chapin, a seasoned entrepreneur from San Diego, who challenged my views on climate change during a conversation in his...

Changsha uses engineering expertise to engage in BRI

BEIJING, June 21, 2025 /PRNewswire/ -- A report from China Daily Engineering machinery is a specialty of Changsha in Central China's Hunan province and a...

DDB Worldwide Named Cannes Lions 2025 Network of the Year for the Second Time in Two Years

Omnicom Network Achieves Record Number of Wins in 76-Year History Under Recently Appointed Global Leadership CANNES, France, June 21, 2025 /PRNewswire/ -- DDB Worldwide, part...

DDB Worldwide Named Cannes Lions 2025 Network of the Year for the Second Time in Two Years

Omnicom Network Achieves Record Number of Wins in 76-Year History Under Recently Appointed Global Leadership CANNES, France, June 21, 2025 /PRNewswire/ -- DDB Worldwide, part...

DDB Worldwide Named Cannes Lions 2025 Network of the Year for the Second Time in Two Years

Omnicom Network Achieves Record Number of Wins in 76-Year History Under Recently Appointed Global Leadership CANNES, France, June 20, 2025 /PRNewswire/ -- DDB Worldwide, part...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsDevelopment